Stephen E. Ettinghausen

Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

Steven A. Rosenberg, Michael T. Lotze, Linda Muul et al. · New England Journal of Medicine · 1985 · 2.6K citations

Medicine, Immunology, Oncology +15

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

Michael T. Lotze, Yvedt L. Matory, Stephen E. Ettinghausen et al. · The Journal of Immunology · 1985 · 614 citations

Life Sciences, Immunology, Pharmacology +9

Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2.

Maury Rosenstein, Stephen E. Ettinghausen, Steven A. Rosenberg · The Journal of Immunology · 1986 · 530 citations · Full text

Medicine, Immunology, Pharmacology +13

Clinical effects and toxicity of interleukin-2 in patients with cancer

Michael T. Lotze, Yvedt L. Matory, Anthony A. Rayner et al. · Cancer · 1986 · 358 citations · Full text

Life Sciences, Immunology, Oncology +13

Pseudomyxoma peritonei syndrome.

Paul H. Sugarbaker, Brigitte M. Ronnett, Ann Archer et al. · PubMed · 1996 · 261 citations